Atlas FDA

NOVOSTE(TM) BETA-CATH(TM) SYSTEM

FDA premarket approval P000018/S001 · decided 2000-12-13

Approval details

PMA number
P000018
Supplement
S001
Supplement type
Special (Immediate Track)
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
NOVOSTE(TM) BETA-CATH(TM) SYSTEM
Generic name
Intravascular radiation delivery system
Applicant
Best Vascular, Inc.
Date received
2000-11-14
Decision date
2000-12-13
Days to decision
29 days
Decision code
APPR
Product code
MOU
Advisory committee
Cardiovascular
Expedited review
No
Location
Norcross, GA
Statement
APPROVAL FOR THE ADDITION OF A PRECAUTION TO THE ISOTOPE IDENTIFICATION LABEL.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.